Novartis
Novartis profits rise despite coronavirus sales swings
Sales were mostly affected by lower new patient starts and significant reduction in patient visits to physicians, said Novartis
Aurobindo buys Novartis arm
The transaction will be the largest outbound investment by an Indian pharma company.
Novartis breast cancer therapy gets FDA breakthrough
Designation covers initial endocrine-based treatment of pre- or perimenopausal women with hormone-receptor positive.
1 of 1